How PBI/Gordon Companies leveraged our Sirolimus API Market report
VM Intelligence · Sample preview · Healthcare and Pharmaceuticals · Forecast 2027–2033
Eczema Traitment Phototherapy Lamp Market
- By Lamp Type: Narrowband UVB Lamp, Broadband UVB Lamp, UVA Lamp, PUVA Lamp
- By End User: Hospitals, Dermatology Clinics, Home Care Settings, Specialty Skin Care Centers
- By Technology: Fluorescent Lamps, LED Phototherapy Lamps, Excimer Laser Devices
- By Application: Eczema Treatment, Psoriasis Treatment, Vitiligo Treatment, Other Photodermatoses
- By Product Form: Handheld Phototherapy Devices, Full-body Phototherapy Units, Targeted Phototherapy Devices
Key Highlights
A snapshot of what the full report proves- 01 Market size - $X,XXX.XM global market in 2025 - the verified base-year revenue. Executive Summary →
- 02 Forecast - Full 2033 market projection modelled inside - unlock the forecast value to see where the market lands. Market Outlook →
- 03 Growth - Year-by-year CAGR across 2027–2033 - unlock the growth rate and the full model. Market Outlook →
- 04 Leading segment - Narrowband UVB Lamp leads By Lamp Type at XX% share. Market, by Service Type →
- 05 Global coverage - Sized across 5 regions and 20 countries, each broken out by segment. Market, by Geography →
- 06 Competitive landscape - 15 companies profiled with SWOT, benchmarking and market-share analysis. Company Profiles →
Inside the Report
12 chapters · 289 pages- 01 Introduction Definition, segmentation & scope p.12 →
- 02 Research Methodology How the numbers were built p.20 →
- 03 Executive Summary The market in one chapter p.34 →
- 04 Market Outlook Drivers, restraints, trends p.66 →
- 11 Competitive Landscape 5 sections p.174 →
- 12 Company Profiles 15 players: SWOT & benchmarking p.182 →
Full report · locked preview
Everything inside the Eczema Traitment Phototherapy Lamp Market report
A complete, evidence-based study - 12 chapters and 121 sections covering market size, segmentation across 5 axes, regional analysis and 15 company profiles, forecast to 2033.
Segmentation covered
Companies profiled
★★★★★ Excellent
15 players profiled - tiered by revenue contribution, footprint and R&D capability.
ACE Matrix · p.153 →Philips
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.155 →Daavlin
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.160 →National Biological Corporation (NB Corp)
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.166 →Waldmann
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.173 →UV Therapy
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.178 →Herbert Waldmann GmbH & Co. KG
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.184 →MediLight
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.191 →Dr. Hönle AG
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.196 →Heraeus Medical
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.202 →Waldmann Lichttechnik GmbH & Co. KG
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.209 →UVTech
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.214 →Lumenis
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.220 →Dermalight
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.227 →Solarc Systems
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.232 →Bioderm
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.238 →Market estimates & forecast (USD Million)
Fig. 15 · p.34 →Segment mix, 2033 (% share)
Fig. 16 · p.35 →- Narrowband UVB Lamp66.1
- Broadband UVB Lamp7.5
- UVA Lamp14.4
- PUVA Lamp12.0
Regions, 2025 → 2033 (USD Mn)
§6.1 · p.75 →Top countries, 2033 (USD Mn)
§6.2 · p.78 →Year-over-year growth (%)
§3.12 · p.44 →CAGR by region (%)
Fig. 22 · p.71 →Market share by company, 2033 (%)
Fig. 41 · p.152 →- Philips18.3
- Daavlin23.8
- National Biological Corporation (NB Corp)11.5
- Waldmann7.1
- UV Therapy4.3
- Herbert Waldmann GmbH & Co. KG7.0
- Others28.0
Segment contribution to growth (%)
Fig. 18 · p.39 →Competitive positioning (ACE matrix)
Fig. 40 · p.153 →Adoption & penetration (% of addressable)
Fig. 12 · p.31 →Revenue by application (USD Mn)
§5.3 · p.62 →Demand by end-use (USD Mn)
§5.4 · p.66 →Average selling price trend (index, 2025=100)
Fig. 27 · p.58 →Top companies by revenue, 2033 (USD Mn)
Fig. 42 · p.155 →Revenue by region, 2033 (%)
Fig. 20 · p.70 →- North America30.4
- Europe25.1
- Asia Pacific21.9
- Latin America13.0
- Middle East and Africa9.6
8 players benchmarked across 6 dimensions — scored 0–100 from share, portfolio, reach, innovation, financials and installed base. Methodology · §8.1 · p.160 →
Competitive scorecard (score 0–100)
Table 31 · p.161 →| Company | Market share | Product portfolio | Geographic reach | Innovation & R&D | Financial strength | Customer base | Composite |
|---|---|---|---|---|---|---|---|
| Philips | 81 | 83 | 86 | 80 | 74 | 74 | 80 |
| Daavlin | 83 | 93 | 69 | 78 | 86 | 77 | 81 |
| National Biological Corporation (NB Corp) | 79 | 68 | 69 | 78 | 80 | 65 | 73 |
| Waldmann | 73 | 65 | 64 | 78 | 72 | 65 | 70 |
| UV Therapy | 57 | 75 | 60 | 71 | 55 | 68 | 64 |
| Herbert Waldmann GmbH & Co. KG | 59 | 55 | 68 | 59 | 49 | 51 | 57 |
| MediLight | 46 | 57 | 54 | 46 | 55 | 51 | 52 |
| Dr. Hönle AG | 41 | 57 | 37 | 41 | 59 | 48 | 47 |
Vendor positioning (presence × innovation)
Fig. 43 · p.163 →Strengths profile (top 3 players)
Fig. 44 · p.165 →- Philips
- Daavlin
- National Biological Corporation (NB Corp)
Capability coverage
§8.3 · p.168 →| Company | Global delivery | R&D depth | Digital platform | Sustainability | After-sales | Custom solutions |
|---|---|---|---|---|---|---|
| Philips | ◐ | ◐ | ✓ | ✓ | ◐ | − |
| Daavlin | ◐ | ✓ | ◐ | ◐ | ✓ | ◐ |
| National Biological Corporation (NB Corp) | ✓ | ◐ | − | ◐ | ✓ | ◐ |
| Waldmann | ✓ | ✓ | − | ✓ | ◐ | ◐ |
| UV Therapy | ◐ | ◐ | − | ◐ | ◐ | ◐ |
| Herbert Waldmann GmbH & Co. KG | ◐ | ◐ | − | − | − | ◐ |
| MediLight | − | − | − | − | ◐ | − |
| Dr. Hönle AG | − | ◐ | − | − | − | − |
✓ Full ◐ Partial − Limited
Overall competitive index (composite, ranked)
Fig. 45 · p.170 →Competitive tiers
§8.4 · p.172 →Leader2
Set the pace on share, breadth and innovation.
Challenger2
Strong scale, closing on the leaders.
Contender2
Focused players with pockets of strength.
Niche2
Specialists in a single segment or region.
Go-to-market strategy
Land Lamp Type in North America, then scale across Eczema Traitment Phototherapy Lamp Market — a $182M beachhead inside a $3.21B market.
Ideal customer profile (who to sell to)
§GTM 1 · p.190 →Narrowband UVB Lamp
Best fit — highest urgency & budget in Lamp Type.
Broadband UVB Lamp
Strong fit — clear ROI and a fast path to value.
UVA Lamp
Emerging fit — growing demand, longer sales cycle.
Market-entry sequence (beachhead → scale)
Fig. GTM 1 · p.192 →Beachhead · 2025–2026
Win Lamp Type in North America
Concentrated ICP, fastest proof and references.
Expand · 2026–2028
Add End User & next regions
Repeat the motion in adjacent, look-alike segments.
Scale · 2028–2033
Full-market coverage + Technology
Multi-channel, platform & ecosystem plays.
Channel mix (routes to market)
§GTM 3 · p.195 →Positioning & messaging
§GTM 2 · p.194 →For Lamp Type leaders who need defensible market intelligence, VM Intelligence is the fastest, source-cited way to size, segment and win Eczema Traitment Phototherapy Lamp Market — unlike generic, static research.
Live & source-cited
Every figure triangulated from 600K+ sources and traceable.
Ready in minutes
A full, tailored report compiled on demand — not weeks.
Scope you control
Pick the chapters, regions and companies that matter.
GTM funnel & unit economics (conversion · CAC / LTV)
Fig. GTM 2 · p.198 →Investment thesis
Eczema Traitment Phototherapy Lamp Market is a durable-growth opportunity — $4.70B by 2033, compounding at 7.0%.
Market opportunity (TAM · SAM · SOM)
Fig. 3 · p.14 →Growth trajectory (USD Million)
Fig. 4 · p.16 →Why invest now
§2.1 · p.10 →7.0% CAGR
Demand compounds through 2033, outpacing GDP across Lamp Type.
Global tailwinds
North America leads today; fastest gains coming from emerging regions.
Structural shift
Adoption in Lamp Type moving from early to mainstream — durable secular demand.
Consolidation upside
15+ players, no runaway leader — room to build scale and roll up share.
Investment highlights
§2.2 · p.12 →Return scenarios (2033 market value)
Fig. 6 · p.22 →Key risks & mitigants
§9.1 · p.180 →- Input-cost volatilityLong-term supply contracts & hedging
- Regulatory / policy shiftsDiversified exposure across 5 regions
- Technology disruptionR&D pipeline & End User optionality
- Customer concentrationBroaden installed base beyond top accounts
Board pack · executive summary
Eczema Traitment Phototherapy Lamp Market — a $2.70B market by 2033. Plan: grow share from 10.5% to 18.0%.
Strategic scorecard (current vs 2033 target)
Table 1 · p.6 →| Objective | Current | Target · 2033 | Status |
|---|---|---|---|
| Market share | 10.5% | 18.0% | On track |
| Revenue | $259M | $486M | On track |
| Geographic coverage | 2 of 5 regions | 5 of 5 regions | At risk |
| Segment coverage | 3 of 5 axes | 5 of 5 axes | On track |
| Gross margin | 33.8% | 40.9% | At risk |
| Customer retention | 86.8% | 96.1% | Behind |
Where to play (strategic priorities)
§1.2 · p.8 →Lead segment
Win in Lamp Type
Largest revenue pool and fastest secular demand — concentrate to build share here first.
Geographic
Expand across North America & beyond
Deepen the leading region, then scale into the fastest-growing emerging markets.
Adjacency
Build End User capability
A defensible second engine — invest in End User to widen the moat and cross-sell.
Strategic roadmap (2025–2033)
Fig. 1 · p.10 →Phase 1 · Foundation
2025–2027
- Secure core Lamp Type share
- Fix unit economics
- Stand up data & ops
Phase 2 · Scale
2028–2030
- Enter new regions
- Launch End User
- Selective M&A
Phase 3 · Lead
2031–2033
- Category leadership
- Premium mix & margin
- Platform & ecosystem
Board decisions & asks
§1.4 · p.14 →- Approve $54M capacity & capability investment
- Greenlight bolt-on M&A in End User
- Authorise North America expansion plan
- Fund R&D program for Lamp Type leadership
Risk watchlist (RAG)
§9 · p.180 →- Demand / macro slowdownAhead
- Competitive share lossOn track
- Input-cost & supply riskAhead
- Regulatory / policy changeOn track
- Execution & talentBehind
Sales deck · value proposition
Win the Eczema Traitment Phototherapy Lamp Market conversation — a $1.83B market you can size, segment and defend in minutes.
Who buys (target personas)
§1.1 · p.4 →Product / BU leader
Head of Lamp Type
Goal Grow share in Lamp Type
Pain Blind spots on demand, pricing & competitors.
Regional GM
North America lead
Goal Prioritise the right markets
Pain No granular, country-level view of the market.
M&A / strategy
Strategy & Corp Dev
Goal Find where to invest or acquire
Pain Slow, inconsistent third-party research.
From pain to solution
§1.2 · p.6 →The business case (ROI)
Fig. 2 · p.9 →Why buyers trust it (proof points)
§1.3 · p.12 →Coverage includes
Objection handling
§1.4 · p.14 →“We already have market data.”
This triangulates 600K+ sources into one current, defensible view — not another silo.
“How do we know it’s accurate?”
Analyst-reviewed, and every figure is source-cited and traceable to its origin.
“It’s not in the budget.”
A fraction of a single analyst-day — and it pays back on the first decision it informs.
“We need it tailored to us.”
Choose the chapters, regions and companies before you build — you only pay for scope.
What you get (packages)
§1.5 · p.16 →Report
- Full multi-chapter report
- Market size, share & forecast
- Segment & regional breakdowns
- PDF + editable Excel + PPT
Report + Add-ons
- Everything in Report
- Interactive Visualizer
- Competitive benchmarking
- Investor / board / sales decks
Enterprise
- Multiple reports & markets
- Team seats & sharing
- Analyst support & custom scope
- API / data-feed options
Almost there
Access your Eczema Traitment Phototherapy Lamp Market report
Sign in to unlock the full report - it’s compiled live and ready in minutes.
Your report is ready to access
Eczema Traitment Phototherapy Lamp Market Report is ready
Verify your email to unlock it. We sent a 6-digit code to your inbox.
That code is invalid or expired. Please try again.
Trusted by strategy, finance & consulting teams
Related Reports
Healthcare and Pharmaceuticals · scroll →Phenylacetic Acid Lauryl Alcohol Ester Market
Market size, share, segmentation and regional forecast.
$5.2B market · 2025 base year
View reportEczema Cream Market
Market size, share, segmentation and regional forecast.
$4.0B market · 2025 base year
View reportEczema Care Products Market
Market size, share, segmentation and regional forecast.
$4.4B market · 2025 base year
View reportEczema Care Product Market
Market size, share, segmentation and regional forecast.
$935M market · 2025 base year
View reportSeamless Plastic Tube Market
Market size, share, segmentation and regional forecast.
$2.2B market · 2025 base year
View reporteConsent In Healthcare Market
Market size, share, segmentation and regional forecast.
$5.8B market · 2025 base year
View reportEconomy Finger Pulse Oximeter Market
Market size, share, segmentation and regional forecast.
$4.7B market · 2025 base year
View reportLocalized Autoimmune Disease Diagnostics Market
Market size, share, segmentation and regional forecast.
$535M market · 2025 base year
View reportEconomic Urine Bag Market
Market size, share, segmentation and regional forecast.
$2.4B market · 2025 base year
View reportSystemic Autoimmune Disease Diagnostics Market
Market size, share, segmentation and regional forecast.
$2.3B market · 2025 base year
View reportEconomic Electric Wheelchair Market
Market size, share, segmentation and regional forecast.
$1.5B market · 2025 base year
View reportEconazole Nitrate Cream Market
Market size, share, segmentation and regional forecast.
$3.3B market · 2025 base year
View reportThe showdown
Custom-built vs. off-the-shelf
Scroll to watch them go head-to-head
- Tailored to your exact scope
- Delivered in minutes
- Live, always-current data
- Fully editable data (XLSX)
- You choose the companies
- Source-cited & traceable
- Generic, one-size template
- Waits 2–5 days
- A fixed snapshot in time
- Locked, flat PDF
- Preset company list
- Opaque sourcing
Customer Testimonials
Proof from industry leaders who rely on us
These stories come from the executives who depend on VMR’s intelligence for market entry, expansion, assessment, and planning. Their outcomes and experiences reflect our commitment to clarity.
In their words
Watch clients tell their story
How VMR helped University of Limerick with Anesthesia Monitoring Devices
How VMR helps brands expand into Africa & emerging markets
Unlock your GTM strategy: an Elsewedy Electric success story
Beyond sales data: layering NielsenIQ data to support strategy
How VMR became the trusted partner for United Alloy